Hello,
Can anyone give me some insight into GBS by NGS as well by Hiseq?.
Thanks
Jayakumar S
Can anyone give me some insight into GBS by NGS as well by Hiseq?.
Thanks
Jayakumar S
-
-
Are you looking for specific help with something? Otherwise a google/bing search for "GBS by NGS" brings up plenty of articles. -
There are lots of ways to do GBS and lots of reasons for doing GBS. Most people doing GBS are doing it in a species without a lot of genomic resources, making fixed content genotyping platforms (like Fluidigm) difficult to set up. Others have a good reference genome but like that GBS will report on novel SNPs not assayed by a fixed-content platform. There are trade-offs... GBS is not at the same throughput possible as fixed-content systems and the turnaround time will be greater. There is less control over what is being genotyped, so you can't just pick 1,000 SNPs of interest and check those specifically.Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.comComment
-
GBS by Hiseq & NGS
Thanks for your response.Comment
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Today, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment